文献速递血栓与止血

JTH临床专栏——产科出血:血管性血友病与其他遗传性出血性疾病

JTH in Clinic - Obstetric bleeding: VWD and other inherited bleeding disorders.
PubMed 文献 · J Thromb Haemost · 2022-06-08

遗传性出血性疾病(IBD)患者在妊娠、分娩及产褥期出血风险升高,临床管理需将其视为产后出血高危并采取个体化多学科 approach。本文以一例妊娠期血管性血友病患者为例,展示诊断至产褥期多个决策点缺乏高确定性证据的临床困境,并讨论现有文献与本中心做法,随后简要概述其他IBD与妊娠的考量。

要点

  • 遗传性出血性疾病患者妊娠、分娩及产褥期出血风险升高,应视为产后出血高危。
  • 管理需个体化多学科协作,并让患者参与决策。
  • 胎儿若已知或存在遗传性出血性疾病风险,需考虑胎儿及新生儿出血风险。

核心结论

  • 遗传性出血性疾病孕妇的临床决策常缺乏高确定性证据,本文通过病例讨论现有文献与本中心做法。

研究设计与样本

  • 本文为临床病例讨论与文献综述,以一例妊娠期血管性血友病患者为例,讨论从诊断到产褥期各阶段的决策。

主要发现

  • 遗传性出血性疾病患者在妊娠、分娩及产褥期出血风险较高。
  • 临床管理需将遗传性出血性疾病视为产后出血高危,并采取包含患者参与决策的个体化多学科方法。
  • 当胎儿已知或存在遗传性出血性疾病风险时,需考虑胎儿及新生儿出血风险。

临床怎么用

  • 本研究中心的做法是:在病例从诊断到产褥期的每个阶段,结合现有文献讨论并描述本中心处理方法。

局限性

  • 原文指出,妊娠期遗传性出血性疾病患者的决策常缺乏高确定性证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Individuals with inherited bleeding disorders (IBDs) have higher bleeding risk during pregnancy, childbirth, and the postpartum period. Clinical management requires recognition of the IBD as high risk for postpartum hemorrhage and a personalized multidisciplinary approach that includes the patient in decision making. When the fetus is known or at risk to inherit a bleeding disorder, fetal and neonatal bleeding risk also need to be considered. In pregnant IBD patients, it is common for providers to need to make decisions in the absence of high level of certainty evidence. We here present the case of a pregnant von Willebrand disease patient that reached multiple decision points where there is currently clinical ambiguity due to a lack of high level of certainty evidence. For each stage of her care, from diagnosis to the postpartum period, we discuss current literature and describe our approach. This is followed by a brief overview of considerations in other IBDs and pregnancy.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Johnsen JM, MacKinnon HJ. JTH in Clinic - Obstetric bleeding: VWD and other inherited bleeding disorders. J Thromb Haemost. 2022. PMID: 35621921. doi:10.1111/jth.15770

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。